42 results on '"Toyooka, Shinichi"'
Search Results
2. Demographics, Safety and Quality, and Prognostic Information in Both the Seventh and Eighth Editions of the TNM Classification in 18,973 Surgical Cases of the Japanese Joint Committee of Lung Cancer Registry Database in 2010
3. Expert Consensus Recommendations on Biomarker Testing in Metastatic and Nonmetastatic NSCLC in Asia
4. Hereditary Lung Cancer Syndrome Targets Never Smokers with Germline EGFR Gene T790M Mutations
5. Expert consensus recommendations on biomarker testing in metastatic and non-metastatic non-small cell lung cancer in Asia.
6. Expert Consensus Recommendations on Biomarker Testing in Metastatic and Nonmetastatic NSCLC in Asia
7. EGFR Mutation Testing Practices within the Asia Pacific Region: Results of a Multicenter Diagnostic Survey
8. Detection of EGFR Gene Mutations Using the Wash Fluid of CT-Guided Biopsy Needle in NSCLC Patients
9. Sequential Molecular Changes during Multistage Pathogenesis of Small Peripheral Adenocarcinomas of the Lung
10. Risk Factors for Recurrence and Unfavorable Prognosis in Patients with Stage I Non-small Cell Lung Cancer and a Tumor Diameter of 20 mm or Less
11. Clinical Significance of Epidermal Growth Factor Receptor Gene Mutations on Treatment Outcome after First-line Cytotoxic Chemotherapy in Japanese Patients with Non-small Cell Lung Cancer
12. Rapid Acquisition of Alectinib Resistance in ALK-Positive Lung Cancer With High Tumor Mutation Burden
13. Non-BAC Component but not Epidermal Growth Factor Receptor Gene Mutation is Associated with Poor Outcomes in Small Adenocarcinoma of the Lung
14. A Novel Strategy for Treatment of Metastatic Pulmonary Tumors: Radiofrequency Ablation in Conjunction with Surgery
15. The Effect of Gefitinib on B-RAF Mutant Non-small Cell Lung Cancer and Transfectants
16. A Phase II Study of Trastuzumab Emtansine in HER2-Positive Non–Small Cell Lung Cancer
17. A Multicenter Randomized Controlled Study of Paclitaxel plus Carboplatin versus Oral Uracil-Tegafur as the Adjuvant Chemotherapy in Resected Non–Small Cell Lung Cancer
18. Allele-Specific Role of ERBB2 in the Oncogenic Function of EGFRL861Q in EGFR-Mutant Lung Cancers
19. P1.02-071 Detection of Multiple Low-Frequency Mutations by Molecular-Barcode Sequencing
20. P2.01-032 Impact of Preoperative Serum Anti-60S Ribosomal Protein L29 Levels on Prognosis in Patients Who Underwent Surgery for Non-Small Cell Lung Cancer
21. P2.02-035 The Advantage of Induction Chemoradiotherapy in Bronchoplastic Procedure for Non-Small Cell Lung Cancer Accompanied with Central Disease Region
22. P2.02-009 Clinical Outcomes of Induction Chemoradiotherapy with High Dose Chest Radiation for Locally Advanced Non-Small Cell Lung Cancer Patients
23. P3.02b-121 Targeting miR-200c/LIN28B Axis in Acquired EGFR-TKI Resistance Non-Small Cell Lung Cancer Cells Harboring EMT Features
24. P2.02-054 Impact of Prognostic Nutrition Index for Induction Chemoradiotherapy Followed by Surgery in Locally Advanced Non-Small Lung Cancers
25. P3-233: Risk factors for recurrence and unfavorable prognosis in patients with stage IA non-small-cell lung cancer and a tumor diameter of 20mm or less
26. P2-173: Induction chemotherapy versus induction chemoradiotherapy for pathological N2 non-small cell lung cancer
27. P3-261: A comparison of conventional lobectomy versus video-assisted thoracoscopic surgery lobectomy for stage IA lung cancers using a matched-pair analysis
28. P2-085: Aberrant methylation of RASSF1A in small-sized lung adenocarcinoma and its relationship to clinicopathological features
29. P1-028: Intrapleural perfusion hyperthermo-chemotherapy for patients with carcinomatous pleuritis
30. P3-056: A novel strategy for the treatment of metastatic pulmonary tumors: Radiofrequency Ablation (RFA) in conjunction with surgery
31. A5-04: The impact of EGFR mutation and smoking status on non-small-cell lung cancer patients treated with geftinib
32. P2-182: Feasibility of sleeve lobectomy with induction chemoradiotherapy: Analysis of morbidity and recurrence pattern compared with sleeve lobectomy without induction therapy
33. PD2-2-8: The impact of epidermal growth factor receptor gene status on carcinogenesis of small adenocarcinoma of the lung
34. Risk factors for recurrence and unfavorable prognosis in patients with stage IA non-small-cell lung cancer and a tumor diameter of 20mm or less.
35. A novel strategy for the treatment of metastatic pulmonary tumors: Radiofrequency Ablation (RFA) in conjunction with surgery.
36. A comparison of conventional lobectomy versus video-assisted thoracoscopic surgery lobectomy for stage IA lung cancers using a matched-pair analysis.
37. Feasibility of sleeve lobectomy with induction chemoradiotherapy: Analysis of morbidity and recurrence pattern compared with sleeve lobectomy without induction therapy.
38. Induction chemotherapy versus induction chemoradiotherapy for pathological N2 non-small cell lung cancer.
39. Intrapleural perfusion hyperthermo-chemotherapy for patients with carcinomatous pleuritis.
40. Aberrant methylation of RASSF1A in small-sized lung adenocarcinoma and its relationship to clinicopathological features.
41. The impact of epidermal growth factor receptor gene status on carcinogenesis of small adenocarcinoma of the lung.
42. The impact of EGFR mutation and smoking status on non-small-cell lung cancer patients treated with geftinib.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.